• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOTRONIK AG, BUELACH, SWITZERLAND PK PAPYRUS US 3.0/15; COVERED CORONARY STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOTRONIK AG, BUELACH, SWITZERLAND PK PAPYRUS US 3.0/15; COVERED CORONARY STENT Back to Search Results
Model Number 434888
Medical Device Problem Code Lack of Effect (4065)
Health Effect - Clinical Code Cardiac Tamponade (2226)
Date of Event 04/30/2025
Type of Reportable Event Death
Event or Problem Description
Pk papyrus covered stent systems were selected for treatment of a type iii cs/iv perforation (15 mm length) occurred during post-dilatation of a des.After the first pk papyrus (complaint device) was placed, the perforation was not completely sealed so a second pk papyrus was deployed.A possible edge dissection at the edge of the second stent suspected (reported separately), so an onyx frontier was deployed.Afterwards, an impella was placed and the patient left cath lab to icu.Patient continued to have severe hemodynamic compromise despite increasing mechanical support.Family ultimately decided to withdraw care.Additional patient code e0504.
 
Additional Manufacturer Narrative
The affected pk papyrus stent system was not returned to biotronik and could therefore not be subjected to a technical investigation.Images of the case such as angiographies could also not be obtained.The provided clinical information (pk papyrus device registration form, cathlab report) and the production documentation were reviewed to establish whether a device deficiency contributed to the event.Review of the production documentation confirmed that the device was manufactured according to specifications and fulfilled all the requirements of in-process and final inspection.Based on the provided documentation and the conducted review, no manufacturing related root cause could be identified.The treating physician rated the outcome as no device- but procedure-related complication.It should be noted that the ifu advises the user to select the stent size to match the diameter of the vessel to achieve a final stent diameter to vessel ratio of 1:1.Pk papyrus is indicated for the treatment of acute perforations of native coronary arteries and coronary bypass grafts in vessels 2.5 to 5.0 mm in diameter.As such, this device is typically used in emergent response to a life-threatening adverse procedural event unrelated to use of the pk papyrus.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PK PAPYRUS US 3.0/15
Common Device Name
COVERED CORONARY STENT
Manufacturer (Section D)
BIOTRONIK AG, BUELACH, SWITZERLAND
ackerstrasse 6
buelach CH-81 80
CH  CH-8180
Manufacturer Contact
6024 jean road
lake oswego, OR 97035
8772459800
MDR Report Key22044301
Report Number1028232-2025-02437
Device Sequence Number9018127
Product Code NIV
UDI-Device Identifier07640130447165
UDI-Public(01)07640130447165(17)2512
Combination Product (Y/N)N
Initial Reporter StateGA
Initial Reporter CountryUS
PMA/510(K) Number
H170004
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2025
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source User Facility,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 06/18/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Expiration Date12/18/2025
Device Model Number434888
Device Catalogue Number434888
Device Lot Number12230093
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 05/05/2025
Supplement Date Received by Manufacturer06/18/2025
Initial Report FDA Received Date05/19/2025
Supplement Report FDA Received Date06/18/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured12/20/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Death;
Patient Age83 YR
Patient SexFemale
-
-